Log In
Print
BCIQ
Print
Print this Print this
 

ASP1517, FG-4592

  Manage Alerts
Collapse Summary General Information
Company FibroGen Inc.
DescriptionSmall molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH; EGLN)
Molecular Target Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)
Mechanism of ActionHypoxia-inducible factor prolyl hydroxylase inhibitor
Latest Stage of DevelopmentPhase III
IndicationAnemia
Partner

Astellas Pharma Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today